Skip to content
  • HOME
  • ABOUT

    CPA is the leading national, bipartisan organization exclusively representing domestic producers and workers across many industries and sectors of the U.S. economy.

    • ABOUT CPA
    • STAFF
    • BOARD
    • CONTACT CPA
    • ABOUT CPA
    • STAFF
    • BOARD
    • CONTACT CPA
    LEARN MORE ➔
  • ISSUES

    CPA ADVOCACY ISSUES

    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • NEWSROOM
    Sen. Gillibrand Raises Concerns About China’s Ability To Attract U.S. Biotech Investment, Partners

    Sen. Gillibrand Raises Concerns About China’s Ability To Attract U.S. Biotech Investment, Partners

    June 23, 2026

    THE LATEST

    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY

    Sen. Gillibrand Raises Concerns About China’s Ability To Attract U.S. Biotech Investment, Partners

    CPA Releases New China Transshipment Monitor: Report Reveals $70 Billion in Uncollected Revenue

    Washington’s $70 Billion in Lost Protection: Liberation Day, One Year Later

    Don’t Be Misled by the Falling Value of Chinese Imports

    MORE FROM THE NEWSROOM ➔
  • RESEARCH
  • CONTRIBUTE

    Help us take the next steps to strengthen America's domestic producers.

    Your generous contribution will enable us to keep fighting for the prosperous growth of an industrial strategy in many sectors such as Healthcare, Agriculture, Manufacturing, Trade, Technology & Tax.

    CONTRIBUTE TODAY ➔

Reshoring US Pharmaceutical Production Would Create 800K Jobs

Healthcare, Manufacturing, Working PapersBy Michael StumoMarch 17, 2020

Health, Security, Economic Benefits from Reshoring By Steven L. Byers, PhD and Jeff Ferry With the spreading coronavirus pandemic, Americans are becoming increasingly aware of

China’s dominance of the pharma supply chain is highly dangerous to the US

ArchiveBy Michael StumoMarch 17, 2020

Editor’s note: The silver lining in the coronavirus outbreak is that calls for reshoring medical supplies and devices is becoming very strong. Which will help

China RX Exposes Risks of Dependence on China for Medicines

Buy American, China, HealthcareBy Michael StumoNovember 19, 2019

Excerpt: How did the pharmaceutical industry start sourcing pharmaceuticals in China? After her presentation at the Made in America trade show last month, I met Rosemary

Amazon’s Heavy Recruitment of Chinese Sellers Puts Consumers at Risk

ArchiveBy Michael StumoNovember 15, 2019

Editor’s note. Dangerous Chinese products brought to you by Amazon. Enabled by section 321 de minimis rule that allows higher value tariff free imports than

Carcinogens Have Infiltrated the Generic Drug Supply in the U.S.

ArchiveBy Michael StumoSeptember 13, 2019

Editor’s note: Pharmaceutical ingredients from China are uninspected, contaminated with carcinogens, and often simply ineffective. We need to rebuild this supply chain in the US.

NAFTA 2.0: IS THE SOE CHAPTER A RED HERRING?

ArchiveBy Michael StumoApril 18, 2019

Excerpt: “China’s authoritarian government, size, and anticompetitive intent are more problematic than the ownership structure of the companies in question.  The government can fund them, without

Litigation teaches Chinese valsartan maker the downside of U.S. market

ArchiveBy Michael StumoOctober 11, 2018

Editors note: another case of dangerous pharmaceutical drugs coming in from China. Most active pharmaceutical ingredients come from China, having moved out of the USA.

China is Quietly Becoming the World’s Pharmacy — and There Are Big Risks

ArchiveBy Michael StumoJuly 25, 2018

Editors note: this issue of unsafe imported pharmaceuticals from China is the next big health scare. It will be bigger than the contaminated pet food

Address by Michael Stumo to the John William Pope and Jesse Helms Center Foundations

ArchiveBy Michael StumoMay 21, 2018

Address by Michael Stumo, CEO, the Coalition for a Prosperous America (CPA), to the John William Pope and Jesse Helms Center Foundations. May 11, 2018,

With NAFTA in the crosshairs, Mexican trucking foes sharpen their knives

ArchiveBy Michael StumoFebruary 7, 2017

A controversial part of NAFTA that permits Mexican trucks to roll through the United States may be left on the cutting room floor if the

←1
234567891011
…1213141516→
  • ABOUT
  • NEWSROOM
  • CONTACT
Facebook-f Youtube Linkedin

© 2026 COALITION FOR A PROSPEROUS AMERICA. ALL RIGHTS RESERVED.

Go to Top

⋆ ⋆ ⋆ MENU

  • HOME
  • ABOUT
    • ABOUT CPA
    • STAFF
    • BOARD
    • ADVOCACY
    • MEMBERSHIP
    • HISTORY
    • OUR MISSION
    • OUR VISION
    • CONTACT US
  • ISSUES
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • RESEARCH
  • NEWSROOM
    • THE LATEST
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
  • CONTRIBUTE
Prosper Weekly

DON'T MISS IT!

Subscribe to CPA's exclusive weekly Newsletter ➔

 Share This
 Facebook
 LinkedIn
 Copy

Share on Mastodon